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1ABSTRACT
Impact of pretreatment hydronephrosis on the success rate of shock wave 
lithotripsy in patients with ureteral calculi
Ki Don Chang
Department of Medicine
The Graduate School, Yonsei University
(Directed by Professor Kang Su Cho)
A retrospective study design was used to evaluate the predictors of the one-session 
success rate of shock wave lithotripsy (SWL). We also examined the relationships 
between pretreatment hydronephrosis grade and one-session SWL success rates. 
The medical records of 1,824 consecutive patients who underwent the first session 
of SWL for treatment of urinary stones between 2005 and 2013 were reviewed. 
After exclusion, 700 patients with single, 4–20 mm diameter radiopaque calculus 
were included in the study. The mean patient age was 52.55±13.88 years. The mean 
maximal stone length (MSL) and skin-to-stone distance (SSD) were 9.24±3.91 mm 
and 110.80±18.98 cm, respectively. The average values for mean stone density 
(MSD) and stone heterogeneity index (SHI) were 707.04±272.10 and 
244.90±110.16, respectively. One-session success rate was 68.4%, 75.0%, 75.1%, 
54.0%, and 10.5% in patient with hydronephrosis grade 0, 1, 2, 3, and 4, 
respectively. Patients were classified into success or failure groups based on SWL 
outcome. Multivariate logistic regression analyses revealed that MSL (odds ratio 
2(OR) 0.888, 95% confidence interval (CI): 0.841–0.934, P<0.001), MSD (OR 0.996, 
95% CI: 0.995–0.997, P<0.001), SHI (OR 1.007, 95% CI: 1.005–1.010, P<0.001), 
and pretreatment hydronephrosis grade (OR 0.601, 95% CI: 0.368–0.988, P=0.043) 
were significantly associated with one-session success. Pretreatment grades 3 or 4 
hydronephrosis were associated with failure of SWL in patients with single ureteral 
stone. In the presence of severe hydronephrosis, especially hydronephrosis grade 4, 
physicians should proceed cautiously in choosing and offering SWL as the primary 
treatment for ureteral stone. 
-----------------------------------------------------------------------------------------------------
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3I. INTRODUCTION
Ureteral stone is one of the most common urologic diseases. Affected patients can 
experience extreme pain. There are many options for ureteral stone treatment (e.g., 
shock wave lithotripsy (SWL), and ureteroscopic, laparoscopic, or open surgery). 
Since the 1980s, SWL has been recommended as a non-invasive, effective, first-line 
treatment for small-sized radio-opaque stones (≤2 cm diameter).1 The overall 
stone-free rate after treatment using SWL is 80–90%.2,3 Patient’s age, sex, and stone 
characteristics (stone site, size, and density) are factors associated with stone-free 
rates. The number of stones, a history of urolithiasis, presence of renal colic, degree 
of hydronephrosis, and presence of a double J stent are additional factors associated 
with stone-free rates after treatment using SWL.4-6
Ureteral stone is the most common cause of ipsilateral hydronephrosis. The 
presences of one or more ureteral stones warrant urgent intervention to resolve the 
patient’s symptoms and prevent damaging of renal function. The relationship 
between the degree of preoperative hydronephrosis and stone free rate after SWL 
has been studied. However, unanswered questions remain and a complete 
understanding would aid clinical decision-making during treatment selection.5-8 We 
aimed to investigate the predictors of one-session success rate after treatment using 
SWL; we specifically focused on the significance of pretreatment hydronephrosis in 
patients with a ureteral stone. 
4II. MATERIALS AND METHODS
1. Patient cohort
Medical records were obtained from a database of patients (N=1,824) who 
underwent an initial session of SWL between 1st November 2005 and 31st
December 2014 at Severance Hospital, Seoul, Korea. The study inclusion criteria 
were: single, 4–20 mm, radiopaque calculus located within the ureter on plain-film 
X-rays, presentation within 1 month prior to SWL treatment, and no evidence of 
stone migration. Patients with bilateral ureteral stones, urinary tract congenital 
anomalies, or single kidney, and those who received prophylactic medical expulsion 
therapy, were excluded from the analysis. Data from a total of 700 patients were 
eligible for inclusion in the analysis.
2. Good clinical practice protocols
The study was performed in accordance with all applicable laws and regulations, 
good clinical practices, and the ethical principles described in the Declaration of 
Helsinki. The Institutional Review Board of Severance Hospital approved the study 
protocol (4-2016-0791). The study was exempt from the written informed consent 
requirement because it used a retrospective design and because the patients’ records 
and information were anonymized and de-identified before analysis.
3. Shock wave lithotripsy
5SWL was performed using an electro-conductive lithotripter (EDAP Sonolith 
Praktis, Technomed, and Lyon, France) until 31st December 2011. On 1st January 
2012, this lithotripter was replaced by an electromagnetic generative lithotripter 
(Dornier Compact Delta II lithotripter, Dornier Medtech, Wessling, Germany). All 
SWL procedures were performed using fluoroscopic guidance. The total numbers of 
shocks ranged from 2500 to 4000 in each session, at a rate of 60–90 shock waves 
per minute, and a launch intensity ranging from 16 to 55 MPa.
4. Demographic data and non-contrast computed tomography stone 
characteristics
A detailed medical history that included the number of past stone events was 
obtained for each patient. Stone characteristics such as location, maximal stone 
length (MSL), stone heterogeneity index (SHI), skin-to-stone distance (SSD), and 
mean stone density (MSD) were evaluated. SSD was measured in the axial plane, 
45° from the vertical axis.9 MSL was the longest stone length measured in three 
dimensions on non-contrast computed tomography (NCCT) images. We used the 
GE Centricity system (GE Healthcare Bio-Sciences Corp., Piscataway, NJ) for the 
measuring procedures. MSD was measured using bone windows on the magniﬁed, 
axial NCCT image of the stone in the maximal diameter; the elliptical region of 
interest incorporated the largest cross-sectional area of the stone without including 
adjacent soft tissue.10 The SHI was defined as the standard deviation of the 
Hounsfield units (HU) in the same way used by Lee et al.11 Successful SWL 
6treatment of the ureteral calculus was deﬁned as the patient being rendered 
stone-free and asymptomatic, with clinically insigniﬁcant residual fragments ≤3 mm 
maximal diameter (measured by using a radiograph) within 2 weeks after single 
SWL treatment and not requiring additional treatment within a 3-month follow-up 
period.12
5. Hydronephrosis grading system 
The hydronephrosis grading system was defined according to the degrees of change 
in the upper collecting system and used the Society of Fetal Ultrasound Grade 
system.13 Grade 0 hydronephrosis was defined as no dilatation of the renal pelvis, 
with calyceal walls opposed to each other. Grade 1 was defined as dilatation of the 
renal pelvis without dilatation of the calyces (could also be present in the extra renal 
pelvis), and no parenchymal atrophy. Grade 2 hydronephrosis was defined as 
dilatation of the renal pelvis (mild) and calyces (the pelvicalyceal pattern was 
retained), and no parenchymal atrophy. Grade 3 was defined as moderate dilatation 
of the renal pelvis and calyces, blunting of the fornicies and flattening of the 
papillae, and possible mild cortical thinning. Grade 4 hydronephrosis was defined as 
gross dilatation of the renal pelvis and calyces with a ballooned appearance, loss of 
the borders between the renal pelvis, calyces, and renal atrophy indicated by the 
presence of cortical thinning.
6. Statistical analyses
7The statistical comparisons of the continuous variables from the patients’ 
demographic information were performed using the Student’s or Welch’s 
two-sample t-tests or the Wilcoxon rank sum test. One-way analysis of variance 
(ANOVA) was used subgroup analysis. After ANOVA, Tukey–Kramer’s post hoc 
tests were used for between-group comparisons. Categorical variables were 
compared using Pearson's chi-square tests. Univariate and binomial multivariate 
logistic regression analyses were performed to define the factors that predicted 
post-SWL outcomes. The statistical analyses were performed using R software 
(version 3.0.3, R Foundation for Statistical Computing, Vienna, Austria; 
http://www.r-project.org). 
III. RESULTS
Table 1 presents the results for the baseline characteristics of the 700 patients who 
underwent a first SWL treatment for single ureteral calculus. The mean patient age 
for the cohort was 52.55±13.88 years. The mean MSL and SSD values were 
9.24±3.91 mm and 110.80±18.98 cm, respectively. The mean MSD and SHI values 
were 707.04±272.10 and 244.90±110.16 HU, respectively. The results for 
pretreatment hydronephrosis grade in patients with ureteral calculi were 76 (10.9%) 
cases of grade 0, 383 (46.9%) cases of grade 1, 177 (25.3%) cases of grade 2, 100 
(14.3%) cases of grade 3, and 19 (2.7%) cases of grade 4, hydronephrosis. There 
were 573 (81.9%) cases of upper ureteral stone, 48 (6.9%) cases of mid-ureteral 
8stone, and 79 (11.3%) cases of lower ureteral stone. The overall one-session success 
rate was 69.6%. The data from the study population were divided into two groups 
(treatment success or failure). The results indicated that there were statistical 
differences between the two groups in age (51.85±13.88 years in success group 
versus 54.16±13.80 years in failure group; P=0.042), MSL (8.38±3.23 versus 
11.23±4.57, respectively; P<0.001), MSD (642.63±243.89 versus 854.30±276.48, 
respectively; P<0.001), SHI (252.06±114.08 versus 228.51±98.93, respectively; 
P=0.006), and grade of hydronephrosis (P<0.001). The one-session success rates 
were 68.4%, 75.0%, 75.1%, 54.0%, and 10.5% for patients with hydronephrosis 
grades 0, 1, 2, 3, and 4, respectively (Table 2). The results indicated that there was a 
statistically significant association between hydronephrosis grade and the values for 
MSL and MSD (P<0.001; Table 2 and Figures 1 and 2). The associations between 
hydronephrosis grade and one-session success rate and stone location were also 
significantly different (P<0.001).
9Table 1. Comparison of clinical charicteristics between success and failure group 
after shock wave lithotripsy for ureteral stone 
Total cohort Success group Failure group P-value
Patients, n 700 487 213
Mean age ± SD (yr) 52.55±13.88 51.85±13.88 54.16±13.80 0.042a
Sex (%) 0.206b
Male 454 (64.9) 308 (63.2) 146 (68.5)
Female 246 (35.1) 179 (36.8) 67 (31.5)
Mean MSL ± SD 
(mm)
9.24±3.91 8.38±3.23 11.23±4.57 <0.001a
Mean SSD ± SD 
(cm)
110.80±18.98 110.66±18.90 11.15±19.21 0.751a
Mean MSD ± SD 
(HU)
707.04±272.10 642.63±243.89 854.30±276.48 <0.001a
Mean SHI ± SD 
(HU)




Grade 0 76 (10.9) 52 (10.7) 24 (11.3)
Grade 1 328 (46.9) 246 (50.5) 82 (38.5)
Grade 2 177 (25.3) 133 (27.3) 44 (20.7)
Grade 3 100 (14.3) 54 (11.1) 46 (21.6)
Grade 4 19 (2.7) 2 (0.4) 17 (8.0)
Stone location, n 
(%) 
0.510b
Upper 573 (81.9) 403 (82.7) 170 (79.8)
Middle 48 (6.9) 30 (6.2) 18 (8.5)
Lower 79 (11.3) 54 (11.1) 25 (11.7)
One-session success 
(%)
487 (69.6) 487 (69.6) 0 (0)
aBased on student's or Welch's two-sample t-tests bBased on Pearson's chi-squared 
tests with Yates' continuity correction FSF, first-time stone formers; HU, Hounsfield 
units; MSD, mean stone density: MSL, maximal stone length; n, number; RSF, 
recurrent stone formers; SD, standard deviation; SHI, stone heterogeneity index; 
SSD, skin-to-stone distance
10
Table 2. Comparison of clinical charicteristics among groups according to the grade of hydronephrosis 
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 P-value
Patients, n 76 383 177 100 19
Mean age ± SD, (yr) 51.12±14.54 51.87±13.85 53.54±13.51 54.14±14.24 52.53±13.48 0.434
Sex (%) 0.029b
Male 55 (72.4) 223 (68.0) 112 (63.3) 52 (52.0) 12 (63.2)
Female 21 (27.6) 105 (32.0) 65 (36.7) 48 (48.0) 7 (36.8)
Mean MSL ± SD 
(mm) 7.99 ± 2.80 8.49 ± 3.55 9.29 ± 3.52 11.74 ± 4.82 13.65 ± 3.32 <0.001
a
Mean SSD ± SD 
(cm)
106.85±19.76 110.89±18.57 111.55±18.28 111.08±20.64 116.84±19.38 0.239a
Mean MSD ± SD 
(HU)
694.04±235.47 687.70±283.20 656.23±216.51 809.59±287.51 1026.54±273.84 <0.001a
Mean SHI ± SD 
(HU)
237.16±80.43 238.57±112.69 250.35±108.18 253.72±121.03 287.87±122.07 0.247a
Stone location,
n (%)
Upper 56 (73.7) 283 (86.3) 145 (81.9) 73 (73.0) 16 (84.2)
Middle 5 (6.6) 9 (2.7) 16 (9.0) 15 (15.0) 3 (15.8)
Lower 15 (19.7) 36 (11.0) 16 (9.0) 12 (12.0) 0 ( 0.0)
One-session success 
(%) 52 (68.4) 246 (75.0) 133 (75.1) 54 (54.0) 2 (10.5) <0.001
aBased on student's or Welch's two-sample t-tests bBased on Pearson's chi-squared tests with Yates' continuity correction FSF, 
first-time stone formers; HU, Hounsfield units; MSD, mean stone density: MSL, maximal stone length; n, number; RSF, 
recurrent stone formers; SD, standard deviation; SHI, stone heterogeneity index; SSD, skin-to-stone distance
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Figure 1. Comparison of maximal stone length according to grade of 
hydronephrosis. It shows a statistically significant association between 
hydronep hros is  gr ade and the va lu es  for  MSL (P < 0.001) .
The results also indicated that there were statistically significant differences in 
sex (P=0.008), MSL (P<0.001), MSD (P<0.001), stone location (<0.001), and 
one-session success rate (P<0.001) between the two groups with hydronephrosis 
grade 0–2 versus grades 3 and 4. The univariate logistic regression models 




Figure 2. Comparison of mean stone density according to grade of 
hydronephrosis. It shows a statistically significant association between 
hydronep hros is  gr ade and t he va lu es  for  MSD (P <  0.001) .
after ureteral stone treatment: age (OR: 0.988, 95% CI: 0.976–0.999; P=0.043), 
MSL (OR: 0.822, 95% CI: 0.782–0.861; P<0.001), MSD (OR: 0.997, 95% CI: 
0.996–0.998; P<0.001), higher SHI (OR: 1.002, 95% CI: 1.001–1.004; 
P=0.010), and hydronephrosis grade (OR: 0.309, 95% CI: 0.206–0.463; 
P<0.001). The multivariate analyses revealed that shorter MSL, lower MSD, 
and higher SHI were independent predictors and hydronephrosis grades 3 and 4 
13
were negative predictors of one-session success after SWL treatment for 
ureteral calculi (Table 4).
Table 3. Comparison of clinical characteristics between groups with 
pretreatment hydronephrosis grade 0-2 and grade 3-4 
Total cohort Grade 0-2 Grade 3-4 P-value
Patients, n 700 581 119
Mean age ± SD 
(year)
52.55±13.88 52.28±13.84 53.88±14.07 0.251a
Sex (%) 0.008b
Male 454 (64.9) 390 (67.1%) 64 (53.8%) 
Female 246 (35.1) 191 (32.9%) 55 (46.2%)
Mean MSL ± SD 
(mm)
9.24±3.91 8.67±3.47 12.05±4.66 <0.001a
Mean SSD ± SD 
(cm)
110.80±18.98 110.56±18.67 112.00±20.47 0.451a
Mean MSD ± SD 
(HU)
707.04±272.10 678.94±258.54 844.23±295.23 <0.001a
Mean SHI ± SD 
(HU)





Upper 573 (81.9) 484 (83.3%) 89 (74.8%) 
Middle 48 (6.9) 30 (5.2%) 18 (15.1%)
Lower 79 (11.3) 67 (11.5%) 12 (10.1%) 
One-session 
success (%)
487 431 (74.2%) 56 (47.1%) <0.001b
aBased on student's or Welch's two-sample t-tests
bBased on Pearson's chi-squared tests with Yates' continuity correction
HU, Hounsfield units; MSD, mean stone density: MSL, maximal stone length; n, 
number; RSF, recurrent stone formers; SD, standard deviation; SHI, stone 
heterogeneity index; SSD, skin-to-stone distance
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Table 4. Univariate and multivariate logistic regression of various clinical 
parameters for the prediction of one-session success aftershock wave lithotripsy 
Parameter OR 95% CI P-value
Univariate
Age 0.988 0.976–0.999 0.043
Sex (male) 0.789 0.558–1.110 0.177
MSL 0.822 0.782–0.861 <0.001
MSD 0.997 0.996–0.998 <0.001
SSD 0.999 0.990–1.007 0.750
SHI 1.002 1.001–1.004 0.010
Stone location 
Upper Reference
Middle 0.703 0.385–1.317 0.259





Age 0.992 0.979–1.006 0.267
MSL 0.888 0.841–0.934 <0.001
MSD 0.996 0.995–0.997 <0.001




HU, Hounsfield units; MSD, mean stone density: MSL, maximal stone length; 
n, number; RSF, recurrent stone formers; SD, standard deviation; SHI, stone 
heterogeneity index; SSD, skin-to-stone distance
15
IV. DISCUSSION
During the past decades, there have been significant changes in the management 
of urinary stone disease. Before the 1980s, open surgery treatment modality was 
used for most cases. This approach has been replaced by the use of minimally 
invasive surgical procedures such as ureterolithotomy, percutaneous 
nephrolithotomy, and SWL. Of these various options, SWL has been established
as the preferred treatment for urinary stones due to its noninvasive character, 
few absolute contraindications, and resulting favorable clinical outcomes.14,15
However, if a satisfactory outcome for SWL is not expected for a specific 
clinical situation, then the other benefits (e.g., non-invasiveness) are no longer 
available to the patient. Therefore, it is essential to accurately predict individual 
treatment outcome in terms of proper treatment selection for patients who are 
candidates for SWL. 
Previous studies of SWL success rates have revealed that age, sex, and stone 
characteristics (stone site, size, and density) are factors associated with 
post-treatment stone-free rates.5,8 Number of stones, a history of urolithiasis, the 
presence of renal colic, the degree of hydronephrosis, and use of a ureteral stent 
are other factors that affect success rate.6 MSL is a potentially useful 
independent predictor of SWL outcome.5,6 Patients with larger stones are more 
likely to experience failure of treatment and require further intervention.16 MSD 
is also an independent factor associated with SWL outcome.17 MSD is the mean 
16
value of the HU of each pixel in a specific stone area and can be easily 
determined from the NCCT image using a picture archiving and communication 
system.18 This factor is also an independent predictor of SWL outcome.11 SSD 
has been extensively investigated as a predictor of SWL success, but its use 
remains controversial for patients with ureter stones; SSD was a significant 
factor in one-half of all published studies.9 Recently, SHI was introduced as a 
novel independent predictor of SWL success in patients with ureteral stone and 
a useful clinical parameter for stone fragility.11 Other studies of stone site found 
that treatment of proximal and distal ureteral stones results in better outcomes 
compared with treatment of mid-ureteral stones. However, the results of recent 
studies suggest that there is no differences between-group in stone site and 
treatment results.6,19 A history of urolithiasis has been reported as a negative 
factor affecting SWL success.20,21 Ureteral stenting is a significant factor 
affecting stone-free rates.19 Our study revealed that MSL, MSD, SHI, and 
severe hydronephrosis were significant predictors of one-session success rate 
after SWL treatment of single ureteral stone.
Several studies have evaluated the effects of preoperative hydronephrosis on the 
success rate of SWL; their findings have been inconsistent.5-8 El-Assmy et al. 
divided a total of 215 patients with single distal ureteral stone into two groups 
according to the absence or presence of hydronephrosis. There were no 
significant differences between the degree of stone-induced hydronephrosis and 
SWL outcome (83.2% in the non-hydronephrotic group versus 74.2% in 
17
hydronephrotic group, p=0.27).7 They performed a similar study of 284 patients 
with proximal ureteral stone and found that the stone-free rate was 80.3% in the 
hydronephrotic group, compared with 89.1% in the patients without 
hydronephrosis (p=0.12).7 The results of Wang et al.’s  multivariate analysis 
also suggested that hydronephrosis was not a significant factor for SWL 
treatment success rate (OR: 1.272, 95% CI: 0.471–3.433; p=0.635).6 In contrast, 
Kageyama et al. found that mid to lower ureteral calculi and moderate-to-severe 
hydronephrosis were negative predictive factors of SWL treatment success 
rate.8 Delakas et al. also found that the likelihood of SWL treatment failure 
increases with as the severity of the obstruction increases; hydronephrosis was 
associated with poorer results after SWL treatment (borderline significance; 
OR: 1.93, 95%CI: 0.99–3.77; p=0.053).5 The results of our multivariate 
analyses indicated that severe hydronephrosis (grades 3 & 4) was independent 
predictor of a poorer outcome after SWL treatment for ureteral calculi (Table 4).
Generally, ureteral stones cause sudden ureteral obstruction that results in the 
development of hydronephrosis; continuous obstruction results in deterioration 
of renal function. Hydronephrosis has adverse effects on renal function and 
decreases ureteral peristalsis and hydraulic pressure. These changes may 
adversely affect the expulsion of ureteral stones. This relationship may help 
explain our results. Severe hydronephrosis can also be linked to ureteral stone 
impaction into the ureteral mucosa. Impacted stones are frequently associated 
with ureteral polyps or strictures. A chronically impacted stone may cause 
18
inflammation and edema of the ureteral wall; these changes may also involve 
the surrounding tissues. The impacted stone can thus cause a more complete 
ureteral obstruction that result in a severe hydronephrosis. Impacted ureteral 
calculi are more difficult to fragment using SWL because of the lack of a 
natural expansion space for the targeted stones. There are currently two clinical 
definitions used for impacted stones.22 The first commonly used definition of 
impaction is the inability to pass a wire or catheter beyond the stone at the 
initial attempt.23 The second definition of impaction is that the stone has 
remained at the same location in the ureter for more than 2 months.24
Most urologists know that impacted stones are much more resistant to treatment 
using SWL. However, if currently available definitions for stone impaction are 
used, it is almost impossible to determine whether a specific ureteral stone is 
impacted at initial diagnosis. For these reasons, severe hydronephrosis can be 
used as ancillary clinical evidence of ureteral stone impaction in patients with 
ureteral stone when SWL is being considered as a primary treatment. European 
Association of Urology (EAU) guidelines recommend laparoscopic 
ureterolithotomy for treatment of large impacted stones when endoscopic 
lithotripsy or SWL has failed.25 However, our study revealed that the 
one-session success rates were 54.0% and 10.5% in patient with hydronephrosis 
grades 3 and 4, respectively (Table 2). Therefore, even though SWL is less 
invasive compared with surgical lithotripsy; we are not sure whether physicians 
should offer SWL as a first-line therapy for ureteral stone patients with 
19
concomitant grade 4 hydronephrosis. Physicians and patients should discuss this 
low SWL performance rate before selection of SWL as a treatment for ureteral 
stones with accompanying grade 4 hydronephrosis.
This study had some inherent limitations because the use of a retrospective 
study design may have introduced sampling bias. However, we used a relatively 
large cohort of patients who underwent SWL for treatment of single ureteral 
stone. The presence of renal stones and anatomical considerations including the 
location of calyx and renal pelvic stones or stones in the infundibulopelvic 
angle were additional possible sources of bias. To overcome this type of 
limitation and more clearly elucidate the effects of various stone-related factors 
on SWL outcomes, we limited the study population to patients who only had 
ureteral stones. Unlike previous studies, we also classified hydronephrosis grade 
into five groups using a current grading system. This approach resulted in a 
better characterization of the contribution of hydronephrosis to treatment 
outcome. Prospective studies that use large sample sizes are needed to confirm 
our results regarding the relationships between pretreatment hydronephrosis and 
stone clearance.
V. CONCLUSION
The presence of grades 3 or 4 hydronephrosis before SWL was a negative
predictive factor for one-session success in patients treated for a single ureteral 
20
stone. Severe hydronephrosis can be used as an indicator of possible ureteral 
stone impaction. In the presence of severe hydronephrosis, especially grade 4 
hydronephrosis, physicians should be cautious when choosing and offering 
SWL as the primary treatment for ureteral stone.
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지난 30년 동안 충격파쇄석술(shock wave lithotripsy; SWL)은
2cm 이하의 방사선비투과성 요관결석의 1차 치료로 권장되어 왔다. 
본 연구는 요관 결석 환자에서 충격파 쇄석술의 성공율에 영향을
미치는 요인을 분석하고, 특히 치료 전 환측 수신증과
충격파쇄석술의 성공율간의 관계를 알아보고자 한다. 2005년부터
2013년까지 초회 충격파쇄석술을 시행 받은 환자 1,824명을
의무기록을 후향적으로 조사하였고, 최종적으로 4-20mm 크기의
방사선 비 투과성 단일 요관결석을 가진 700명의 환자 데이터를
분석하였다. 환자의 평균 나이는 52.5세였고 평균 maximum stone 
length (MSL)값과 skin-to-stone distance (SSD)값은 각각
9.24±3.91 mm, 110.80±13.88 cm였다. Mean stone density (MSD)와
stone heterogeneity (SHI)의 평균값은 각각 707.04±272.10
Hounsfield unit 및 244.90±110.16였다. 수신증은 총 5등급으로
나누었으며 0등급이 76명 (10.9%), 1등급이 383명 (46.9%), 2등급이
177명 (25.3%), 3등급이 100명 (14.3%)이엇고, 4등급은 19명
(2.7%)으로 나타났다. 전체 대상군을 충격파쇄석술 성공군과
실패군으로 나누어서 비교 분석하였다. 두 군의 나이 (P=0.042), MSL 
(P<0.001), MSD (P<0.001), SHI (P=0.006), 그리고 수신증 등급
(P<0.001)은 통계학적으로 차이를 보였다. 수신증 등급을 0-2등급
군과 3-4등급 군으로 나누어 비교하였을 때, MSL, MSD 및 결석의
위치는 유의한 차이를 보였고 (P<0.001), 충격파쇄석술 성공율에서도
의미있는 차이가 관찰되었다 (P<0.001). 다양한 임상인자들이
충격파쇄석술의 성공율에 미치는 영향을 알아보기 위한 다 변량
분석에서는 MSL (odds ratio (OR) 0.822, P<0.001), MSD (OR 0.996, 
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P<0.001), SHI (OR 1.007, P<0.001), 그리고 수신증 등급(OR 0.601, 
P=0.043)이 독립적인 예측인자임을 확인할 수 있었다. 결론적으로
3-4등급의 수신증을 동반한 요관결석에서는 충격파쇄석술 성공율이
감소함을 알 수 있었다. 따라서 심한 수신증을 동반한 요관결석
환자에서 충격파쇄석술을 선택함에 있어 신중할 기해야 한다. 
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